InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by PASSERI DANIEL R, Chairman & CEO. Officer active across 1 companies, notably Cue Biopharma, Inc.. Aggregated, 5 reports have been published. Total volume traded: €85k. The latest transaction was filed on 24 September 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
75,000 shares
Common Stock
SEC:0001209191-22-022570:0·
75,000 shares
Common Stock
SEC:0001209191-21-060022·
75,000 shares
Common Stock
SEC:0001209191-21-060022:0·
€42,6323,400 shares@ €12.5389100.0% of flow
Common Stock
SEC:0001209191-21-057784·
Ideal exit: 21 Jun 2022 (T+270)
€42,6323,400 shares@ €12.53890.14% mcap50.0% of flow
Common Stock
SEC:0001209191-21-057784:0·
Ideal exit: 21 Jun 2022 (T+270)
5 of 5 declarations
About PASSERI DANIEL R
Daniel R. Passeri is the Chief Executive Officer of Cue Biopharma, Inc. He leads the company, which specializes in the development of biological therapies. His leadership is essential for research and development.
